Wealth Enhancement Advisory Services, LLC Lexicon Pharmaceuticals, Inc. Transaction History
Wealth Enhancement Advisory Services, LLC
- $49 Billion
- Q1 2025
A detailed history of Wealth Enhancement Advisory Services, LLC transactions in Lexicon Pharmaceuticals, Inc. stock. As of the latest transaction made, Wealth Enhancement Advisory Services, LLC holds 69,207 shares of LXRX stock, worth $51,213. This represents 0.0% of its overall portfolio holdings.
Number of Shares
69,207Holding current value
$51,213% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding LXRX
# of Institutions
135Shares Held
196MCall Options Held
310KPut Options Held
77.3K-
Artal Group S.A. Luxembourg, N4136MShares$101 Million100.0% of portfolio
-
Black Rock Inc. New York, NY9.89MShares$7.32 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA9.56MShares$7.07 Million0.0% of portfolio
-
Schonfeld Strategic Advisors LLC New York, NY8.21MShares$6.08 Million0.03% of portfolio
-
Geode Capital Management, LLC Boston, MA3.69MShares$2.73 Million0.0% of portfolio
About LEXICON PHARMACEUTICALS, INC.
- Ticker LXRX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 188,726,000
- Market Cap $140M
- Description
- Lexicon Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of pharmaceutical products. Its orally-delivered small molecule drug candidates under development comprise Sotagliflozin that completed Phase III clinical trials for the for the treatment of heart failure and type 1 diabetes; ...